Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS)

Interest Subvention: Up to 5% (6% for SC/ST) on loans up to ₹10 Cr for 3 years on a reducing balance.

The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers is announce the Revamped Pharmaceuticals Technology Upgradation Assistance (RPTUAS) Scheme. It is a significant step in government’s efforts to help upgrade the technological capabilities of our pharmaceutical industry and ensure its alignment with the global standards.

The approval of the revised Scheme follows a comprehensive review by the Scheme Steering Committee in light of the requirements of the revised Schedule-M of the Drugs and Cosmetics Rule, 1945 as issued by the Department of Health & Family Welfare on 28/12/2023. The revised guideline aims to support the pharmaceutical industry's up-gradation to the Revised Schedule-M & WHO-GMP standards, enhancing the quality and safety of pharmaceutical products manufactured in our country.

Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS) Objective Image

Objectives

To facilitate existing pharma units to upgrade to Revised Schedule M and WHO-GMP standards.

Benefits

Financial Incentive: Pharmaceutical units with following average turnover criterion for the last three years will be eligible for incentive subject to a maximum of Rs.2.00 crore as under: - Turnover from Rs. 1.00 crore to less than Rs. 50.00 crore: - 20% of investment under eligible activities.
Turnover from Rs. 50.00 crore to less than Rs. 250.00 crore: - 15% of investment under eligible activities.
Turnover from Rs. 250.00 crore to less than Rs. 500.00 crore: - 10% of investment under eligible activities.

Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS) Benefit Image

Eligibility

Existing Pharmaceutical manufacturing units with an average turnover of less than ₹500 crore over the last 3 years.

How to Apply?

Pharma units will apply online in the prescribed proforma for shortlisting under the scheme with a gap analysis of the existing manufacturing unit.

The PMC will examine the gap analysis and recommend sanction of an estimated amount of subsidy for reimbursement to the shortlisted applicant. It will also process the loan application of the applicant in case he opts for loan to augment his/her resources.

The PMC will scrutinize and recommend the proposals to the SSC within one month of the submission of gap analysis. It will also process the loan application of the applicant in the case he opts for the same.

To claim 1st installment of subsidy, the short-listed applicant should submit the requisite Revised Schedule M certificate and CA certified expenditure incurred after 01.01.2024 on eligible activities under the Scheme.

The PMC shall verify the expenditure incurred under eligible activities and recommend the amount eligible under the Scheme.

The SSC will consider the recommendation of the PMC regarding the subsidy amount for each applicant and 50% of the eligible amount (subject to an upper limit of Rs. 50 lakhs)) will be released as 1st installment within 30 days of obtaining requisite documents.

The short-listed applicant should subsequently submit the requisite WHO_GMP certificate and CA certified expenditure incurred after 01.01.2024 on eligible activities under the Scheme.

After obtaining the above items, PMC shall verify the expenditure incurred under eligible activities and submit its recommendations to the SSC for approval.

The SSC will consider the recommendations of the PMC regarding the 2nd and final installment of the subsidy and approve the release of eligible amount (subject to total upper limit of Rs. 1.00 crore for each applicant) within 30 days of obtaining the requisite documents.

The SSC shall be fully competent to approve the deviations from original gap analysis submitted by applicant based on the recommendation of technical committee, for the purpose of calculation of eligible expenditure and reimbursement subsidy under the Scheme.

Apply Now